pmc logo image
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Journal List > Ann Rheum Dis > v.63(Suppl 2); Nov 2004

Formats:
Ann Rheum Dis. 2004 November; 63(Suppl 2): ii92–ii95.
doi: 10.1136/ard.2004.028332.
PMCID: PMC1766776
Copyright notice
Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease
C Buckley, A Filer, O Haworth, G Parsonage, and M Salmon
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
The most surprising feature of the inflammatory response in rheumatoid arthritis is not that it occurs but that it does not resolve. The persistence of the chronic inflammatory response in conjunction with ongoing joint destruction is an all too familiar finding in many patients with rheumatoid arthritis. Despite the use of effective anti-inflammatory agents and disease modifying drugs, a significant proportion of patients with rheumatoid arthritis continue to have resistant disease. Complete clinical remission is unusual for more than six months and a formal cure of the disease remains elusive. In this report we focus on how attempts to address the question of why rheumatoid arthritis persists have led to a different interpretation of the pathogenesis of rheumatoid disease; one in which alterations in stromal cells such as fibroblasts play an important role in the switch from resolving to persistent disease.
Full Text
The Full Text of this article is available as a PDF (154K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Firestein Gary S. Evolving concepts of rheumatoid arthritis. Nature. 2003 May 15;423(6937):356–361. [PubMed]
  • Buckley CD. Science, medicine, and the future. Treatment of rheumatoid arthritis. BMJ. 1997 Jul 26;315(7102):236–238. [PubMed]
  • Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 1996 Nov;39(11):1781–1790. [PubMed]
  • Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001 Apr;22(4):199–204. [PubMed]
  • Dooley MA, Hogan SL. Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol. 2003 Mar;15(2):99–103. [PubMed]
  • Silman Alan J. Commentary: Do genes or environment influence development of rheumatoid arthritis? BMJ. 2002 Feb 2;324(7332):264. [PubMed]
  • Zanelli E, Breedveld FC, de Vries RR. HLA association with autoimmune disease: a failure to protect? Rheumatology (Oxford). 2000 Oct;39(10):1060–1066. [PubMed]
  • Salmon Mike, Akbar Arne N. Telomere erosion: a new link between HLA DR4 and rheumatoid arthritis? Trends Immunol. 2004 Jul;25(7):339–341. [PubMed]
  • Vallejo Abbe N, Weyand Cornelia M, Goronzy Jörg J. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med. 2004 Mar;10(3):119–124. [PubMed]
  • Smolen Josef S, Steiner Günter. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003 Jun;2(6):473–488. [PubMed]
  • Müller-Ladner U, Gay RE, Gay S. Cellular pathways of joint destruction. Curr Opin Rheumatol. 1997 May;9(3):213–220. [PubMed]
  • Cavender D, Haskard D, Yu CL, Iguchi T, Miossec P, Oppenheimer-Marks N, Ziff M. Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc. 1987 Jan;46(1):113–117. [PubMed]
  • Gilroy Derek W, Lawrence Toby, Perretti Mauro, Rossi Adriano G. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov. 2004 May;3(5):401–416. [PubMed]
  • Brady HR, Lamas S, Papayianni A, Takata S, Matsubara M, Marsden PA. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction. Am J Physiol. 1995 Jan;268(1 Pt 2):F1–12. [PubMed]
  • Majno G. Chronic inflammation: links with angiogenesis and wound healing. Am J Pathol. 1998 Oct;153(4):1035–1039. [PubMed]
  • Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001 Jun 15;166(12):7556–7562. [PubMed]
  • Jones Elena A, Kinsey Sally E, English Anne, Jones Richard A, Straszynski Liz, Meredith David M, Markham Alex F, Jack Andrew, Emery Paul, McGonagle Dennis. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002 Dec;46(12):3349–3360. [PubMed]
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 2;284(5411):143–147. [PubMed]
  • Vallejo Abbe N, Yang Hongyu, Klimiuk Piotr A, Weyand Cornelia M, Goronzy Jörg J. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol. 2003 Aug 15;171(4):1732–1740. [PubMed]
  • Pap T, Müller-Ladner U, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2(5):361–367. [PubMed]
  • Buckley CD. Michael Mason prize essay 2003. Why do leucocytes accumulate within chronically inflamed joints? Rheumatology (Oxford). 2003 Dec;42(12):1433–1444. [PubMed]
  • Brouty-Boyé D, Pottin-Clémenceau C, Doucet C, Jasmin C, Azzarone B. Chemokines and CD40 expression in human fibroblasts. Eur J Immunol. 2000 Mar;30(3):914–919. [PubMed]
  • Parsonage Greg, Falciani Francesco, Burman Angela, Filer Andrew, Ross Ewan, Bofill Margarita, Martin Stuart, Salmon Mike, Buckley Christopher D. Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost. 2003 Oct;90(4):688–697. [PubMed]
  • Vaday GG, Lider O. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol. 2000 Feb;67(2):149–159. [PubMed]
  • Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int. 1998 Dec;54(6):2152–2159. [PubMed]
  • Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol. 1997 Aug;151(2):317–322. [PubMed]
  • Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum. 2000 Sep;43(9):2046–2055. [PubMed]
  • Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2(6):477–488. [PubMed]
  • Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest. 2000 Jun;105(12):1663–1668. [PubMed]
  • Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol. 1999 Jun;9(6):233–238. [PubMed]
  • Akbar AN, Salmon M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today. 1997 Feb;18(2):72–76. [PubMed]
  • Zvaifler NJ, Firestein GS. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1994 Jun;37(6):783–789. [PubMed]
  • Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest. 1997 Feb 1;99(3):439–446. [PubMed]
  • Pilling D, Akbar AN, Girdlestone J, Orteu CH, Borthwick NJ, Amft N, Scheel-Toellner D, Buckley CD, Salmon M. Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol. 1999 Mar;29(3):1041–1050. [PubMed]
  • Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord JM, Scheel-Toellner D, Salmon M. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol. 2000 Sep 15;165(6):3423–3429. [PubMed]
  • Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum. 2001 Nov;44(11):2633–2641. [PubMed]
  • Mazzucchelli L, Blaser A, Kappeler A, Schärli P, Laissue JA, Baggiolini M, Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest. 1999 Nov;104(10):R49–R54. [PubMed]
Figures and Tables
Figure 1
Figure 1
Figure 1
 Leucocyte–stromal interactions are involved at every stage in the trafficking of leucocytes into, within, and out of tissues. The molecular basis by which leucocytes leave the circulation and migrate across endothelium has been well (more ...)
Figure 2
Figure 2
Figure 2
 Not all fibroblasts are the same. Fibroblasts from the rheumatoid, or normal synovium look different from fibroblasts from the skin and express different patterns of adhesion and matrix molecules compared with fibroblasts derived from the skin. (more ...)
Figure 3
Figure 3
Figure 3
 The dynamics of the synovial inflammatory infiltrate. The dynamic balance of cells in any tissue compartment depends on the balance of cells that enter, exit, proliferate, or die. Homoeostasis is maintained during normal inflammatory responses (more ...)
Articles from Annals of the Rheumatic Diseases are provided here courtesy of
BMJ Group

PubMed articles by these authors

Links